Effects of Komouni Formulation (Herbal Product of Persian Medicine) With a Low-Calorie Diet on Cardiometabolic Risk Factors in Overweight and Obese Women: A Triple-Blinded Randomized Clinical Trial
Iranian Journal of Pharmaceutical Research · 21.06.2023 · 22 (1)
DOI: 10.5812/ijpr-136114 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Iranian Journal of Pharmaceutical Research, online erschienen am 21.06.2023. Verfasst von Zahra Aghabeiglooei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Medicine, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The prevalence of obesity has almost tripled since 1975, and obesity places a heavy economic burden on healthcare systems. There is a high tendency to use a variety of complementary medicine modalities for weight management among obese patients. Persian Medicine is an ancient medical school practiced for thousands of years in Iran. Found in reliable Iranian traditional resources, Komouni formulation (KF) is a compound medicine that can be effective in the treatment of obesity. It comprises black caraway (Bunium persicum Boiss.), anise (Pimpinella anisum L.), fennel (Foeniculum vulgare Miller), and ajwain (Trachyspemum ammi L.)
Objectives
This study aimed to determine the effects of KF on anthropometric indices and metabolic parameters in overweight and obese women.
Methods
This triple-blinded randomized controlled clinical trial was performed on 70 overweight or obese women aged 20 - 40 years, with a body mass index (BMI) of 25 - 34.9 kg/m2. The subjects were randomly divided into two groups (each group n = 35) to receive a calorie-restricted diet with 2 g/day (500 mg 30 minutes before breakfast, 1000 mg 30 minutes before lunch, and 500 mg 30 minutes before dinner) KF or placebo for 8 weeks. Anthropometric indices, food intake, and biochemical parameters were measured at baseline and after the intervention.
Results
A total of 60 women (intervention = 30; placebo = 30) completed the trial. After the intervention, the KF group experienced a significant reduction in weight (-4.8 vs. -3.2 kg; P = 0.0001), BMI (-1.8 vs. -0.79 kg/m2; P = 0.0001), waist circumference (-5.28 vs. -3.20 cm; P = 0.004), hip circumference (-0.018 vs. -0.008 cm; P = 0.047), fasting blood sugar (-5.6 vs. 0.33; P = 0.025), and low-density lipoprotein (-11.7 vs. 6.7; P = 0.0001), compared to the placebo group. None of the patients in the intervention and placebo groups reported any side effects.
Conclusions
Using KF, along with a calorie-restricted diet, can reduce cardiometabolic risk factors in overweight and obese women. However, further studies are needed to elucidate the efficacy of KF as a complementary therapy in obesity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Traditional Medicine, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Traditional Pharmacy, School of Persian Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Zahra Aghabeiglooei, Nazli Namazi, Mehrdad Karimi, Samaneh Soleymani, Mohammad Hossein Ayati, Hossein Rezaeizadeh
Zitieren
APA
Aghabeiglooei, Z., Namazi, N., Karimi, M., Soleymani, S., Ayati, M. H., & Rezaeizadeh, H. (2023). Effects of Komouni Formulation (Herbal Product of Persian Medicine) With a Low-Calorie Diet on Cardiometabolic Risk Factors in Overweight and Obese Women: A Triple-Blinded Randomized Clinical Trial. Iranian Journal of Pharmaceutical Research, 22(1). https://doi.org/10.5812/ijpr-136114
Vancouver
Aghabeiglooei Z, Namazi N, Karimi M, Soleymani S, Ayati MH, Rezaeizadeh H. Effects of Komouni Formulation (Herbal Product of Persian Medicine) With a Low-Calorie Diet on Cardiometabolic Risk Factors in Overweight and Obese Women: A Triple-Blinded Randomized Clinical Trial. Iranian Journal of Pharmaceutical Research. 2023;22(1). doi:10.5812/ijpr-136114
BibTeX
@article{Aghabeiglooei2023,
author = {Aghabeiglooei, Zahra and Namazi, Nazli and Karimi, Mehrdad and Soleymani, Samaneh and Ayati, Mohammad Hossein and Rezaeizadeh, Hossein},
title = {Effects of Komouni Formulation (Herbal Product of Persian Medicine) With a Low-Calorie Diet on Cardiometabolic Risk Factors in Overweight and Obese Women: A Triple-Blinded Randomized Clinical Trial},
journal = {Iranian Journal of Pharmaceutical Research},
year = {2023},
volume = {22},
number = {1},
doi = {10.5812/ijpr-136114}
}
EUVIMED